A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
United States, MarylandNational Institutes of Health**RECRUITING NOW**Bethesda, Maryland, United States, 20892Contact: Erica Redmond    240-858-3783      Principal Investigator: James Gulley, MD, PhD         United States, MassachusettsMassachusetts General Hospital Cancer Center**RECRUITING NOW**Boston, Massachusetts, United States, 02114Contact: Ryan Sullivan, MD    617-643-3614      Principal Investigator: Ryan Sullivan, MD         United States, New YorkMemorial Sloan-Kettering Cancer Center**RECRUITING NOW**New York, New York, United States, 10065Contact: Claire Friedman, MD    646-888-4247      Principal Investigator: Claire Friedman, MD         Canada, OntarioPrincess Margaret Cancer Centre**RECRUITING NOW**Toronto, Ontario, Canada, M5G 2C4Contact: Lillian Siu, MD    416-946-2911      Principal Investigator: Lillian Siu, MD         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 23, 2023Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments